𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Polymorphic tandem repeat region in interleukin-1α intron 6

✍ Scribed by Sabine Bailly; Francesco S. Giovine; Gordon W. Duff


Publisher
Springer
Year
1993
Tongue
English
Weight
121 KB
Volume
91
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Polymorphism in human IL-1 receptor anta
✍ Joanna K. Tarlow; Alexandra I. F. Blakemore; Andrew Lennard; Roberto Solari; How 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 263 KB

We have investigated the polymorphism in intron 2 of the interleukin-1 receptor antagonist gene and identified two new alleles of the system. We have shown that the polymorphism is caused by the variable copy number of an 86-bp sequence, by using the polymerase chain reaction and primers immediately

Mapping of the interleukin 5 receptor ge
✍ Chaim O. Jacob; Kirk Mykytyn; Terry Varcony; Harry A. Drabkin 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 660 KB

Simple-sequence tandem repeat sequences in the 3' UTR of interleukin 5 (IL5)-receptor gene of human and mouse are polymorphic in their length among humans and different strains of mice. In 20 different human Epstein-Barr virus (EBV)-transformed cell lines, six alleles of IL5R could be distinguished.

A highly polymorphic (ACT)n VNTR (variab
✍ Guglielmina Pepe 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 515 KB

A new, highly polymorphic, region consisting of variable number of tandem repeats (VNTR) is described that occurs within intron 12 of the COLlA2 gene. This VNTR consists of the trinucleotide ACT repeated from 6 to 12 times. Of the six alleles so far detected four are common in the three major races,

Interleukin (IL)-1β, IL-1 receptor antag
✍ I-Ching Chou; Wei-De Lin; Chung-Hsing Wang; Chang-Hai Tsai; Tsai-Chung Li; Fuu-J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

## Abstract Inflammation and genetics may play a role in the pathogenesis of febrile seizures (FSs). We aimed to test whether interleukin‐1β (IL‐1β), IL‐1 receptor antagonist (IL‐1 Ra), IL‐6 promoter, IL‐8, IL‐10, or tumor necrosis factor (TNF) gene polymorphisms could be used as markers of suscept